This video is part of a recent episode of The Doctors, which features Dr. Jessica Wu showcasing the new eyelash enhancement drug, Latisse.

Dr. Wu says that Latisse starts to work in about 4 weeks, and provides “luscious” eyelashes after just 4 months. You apply Latisse to the base of the upper eyelashes once each night “just like liquid eyeliner.” According to Dr. Wu, the results should yield lashes that are 25 percent longer and 100 percent thicker!

See the video for before & after photos; they’re impressive! If you are interested in learning more about Latisse in Rancho Cucamonga, contact us.

A quick survey of public perception may reveal that the concept of male breasts has been transformed; what was once a relatively obscure condition is now approaching the level of pop culture phenomenon.

Journalist Finlo Rohrer, of BBC news, reports that the media – especially the tabloid scrutinization of celebrities – has popularized the concept of ‘man boobs.’ In the summer of 2006, British Prime Minister Tony Blair and conservative party leader, David Cameron, were photographed shirtless, which led several media outlets to “comment on their moobs.”

The weblog www.manboobs.uk, which according to one reader, has “plumbed the depths of poor taste,” pokes fun at the concept, but further popularizes it.  American television sitcoms like Seinfeld and Friends have done the same.  According to Rorher, this popularity could lead to “more men making their way through the surgeon’s doors.”

So what is the deal with male breasts?  Here are a few things you might not know:

  • Gynecomastia – the condition that forms breast tissue in males, is relatively common, and often mistaken for simple excess fat. It can affect newborns, pubescent boys, and adults.  While it isn’t serious (unless it is a sign of something else), it can be rather painful and embarrassing.

  • Obesity will often cause excess breast tissue, but real gynecomastia is caused by a hormone imbalance. In either case, surgery can alleviate the symptoms.

  • Medications, or illegal drugs like marijuana and anabolic steroids can cause gynecomastia. Particular drugs that are used during treatment for prostate cancer are to blame.

  • Gynecomastia can also be caused by genetic conditions like Klinefelter’s Syndrome.

  • Surgery isn’t the only option: in cases of pubertal gynecomastia, the condition will sometimes disappear over time or when puberty is over.  Other cases have shown improvement without any interventions; one case published in the June 2008 issue of Endocrine Practices documents a rare case of bilateral gynecomastia in a 60 year old man. The patient’s examination results were normal, but he reported a daily intake of 3 qts soy milk.  Once the patient ceased his intake of soy milk, his condition improved and his hormone imbalance was resolved.

While underlying issues like hormone imbalance and obesity should always be addressed,  many patients find that surgery is the right choice to correct excess breast tissue.  Surgery can restore a natural masculine appearance. If you are interested in learning more about male breast reduction, contact Inland Cosmetic Surgery for a consultation.

A star-studded Hollywood charity event sponsored by Botox manufacturer, Allergan Inc, had Brooke Shields, Mandy Moore, Marisa Tomei, and other big name celebrities in attendance, supporting the new Latisse Wishes campaign.

The campaign will raise money for the Make-A-Wish foundation, as well as spark interest in the new eyelash enhancement drug.

Latisse is Allergan’s latest eyelash enhancing drug, the first drug to be approved by the FDA for the treatment of hypotrichosis (inadequate eyelashes). When applied to the base of the upper eyelids, Latisse causes longer, thicker eyelashes.

It isn’t a mere coincidence that the Make-A-Wish foundation was chosen as a beneficiary for Allergan’s campaign; the superstitious tradition of “blowing on an eyelash to make a wish come true” provides a clever marketing strategy, now backed by philanthropy.

Beauty expert and participant, Anastasia Soare, enthusiastically expressed her support, saying “I constantly work to help make women’s beauty wishes come true, and now we can help children’s wishes come true through the LATISSE™ Wishes campaign.”

During the event, a $500,000 initial contribution was granted to Make-A-Wish, but Allergan is encouraging consumers to help double the donation amount by visiting www.Latisse.com and registering their support.  From now until the end of the year, the company will donate 5 dollars for each new registration, up to one million dollars.

Latisse, and other eyelash enhancements, are available at Inland Cosmetic Surgery; give us a call for more information.

The incredible growth and success of laser technology has taken the cosmetic surgery industry by storm, and new survey results from the American Academy of Cosmetic Surgery prove it. Results of their annual survey show a major popularity shift toward non-invasive laser treatments, which began around 2005.

AACS president Patrick McMenamin explains the trend: “As we learn more about the cosmetic uses for lasers, the more patients benefit from effective results and quicker recovery time.” Mcmenamin suggests that this progression drives demand even further, which makes laser procedures more affordable. It’s true – the average price of laser resurfacing has dropped almost $500 since 2002.

More survey results include some highly interesting gender statistics on laser resurfacing. The past three years witnessed a 456% increase in males choosing to undergo procedures, while females choosing them grew by 215%.

The most recent data (for 2008) revealed a sharp drop in male use, which is most likely related to the economic recession. Nonetheless, ‘the big picture’ of laser resurfacing shows that it may be the beginning of an exciting trend. As Dr. McMenamin says, “It is an exciting time for both cosmetic surgery patients and physicians.”

At Inland Cosmetic Surgery, we offer several highly-effective laser treatments. For more information, call us for a consultation.

Featured in the latest issue of Archives of Facial Plastic Surgery is a medical study on the safety of the wrinkle relaxing injectable, Reloxin.  The new drug, which is expected to be an alternative to Botox, was evaluated for its use on moderate to severe forehead wrinkles (or glabeller lines).  The results of the study appear optimistic.

While FDA approval has not yet been granted for Reloxin to be sold in the U.S., Medicis Pharmaceutical expects FDA clearance later this year.  They’re introducing Reloxin with the hope that it will be the first direct competitor to Botox, in a market that helped Allergan Inc. net $1.3 billion last year with the wrinkle relaxing drug.

A California dermatologist who was involved in the study commented to Bloomberg news, saying “the side effects are the same as Botox” and “many of our patients liked it even better.”

The active ingredients of Reloxin and Botox are very similar; they each contain a particular ‘botulinum toxin’ that has been proven to relax the muscles that cause wrinkles in the face.

While Reloxin has actually been sold overseas under the name ‘Dysport’ for about 15 years, Botox has still managed to claim over 80 percent of the worldwide market for the neurotoxin.  One market analyst speculates that “Reloxin may be priced 15 percent lower than Botox” which could allow it to take a significant share of that market.

Are spots on your forehead, cheeks, or chest becoming a problem? It might surprise you to know that in many cases skin conditions of this type can be easily treated and minimized. Age spots and skin blotches are common, and you should be happy to know that we carry the Obagi® therapeutic skin care line as a possible remedy.

Many are aware of Obagi, but not everyone knows that it is the top skin care line sold exclusively to physicians. Obagi® has gained a reputation for effectiveness with its Nu Derm® System, also known as Corrective and Enhance®, which smoothes out fine lines, fades brown spots and can correct other skin imperfections in just a few months.

During the aging process, dark spots and uneven skin tone can appear on a person’s face.

A ‘mask’ may even form over the nose and cheek area, especially after a pregnancy or use of birth control. Obagi Clear™ contains prescription strength hydroquinone to correct discoloration and equalize skin tones. Hydroquinone is the active ingredient used for its “fading” properties, which proactively corrects the early signs of damage by regulating the cell production responsible for skin pigment.

Obagi skin care products are far more effective than any over-the-counter product, so they are by prescription.  They are specially formulated to achieve a desired end and they get visibly dramatic results!  Obagi® is considered a medical grade skin care program so speaking with a physician like Dr. Haiavy is necessary before purchasing.

Why delay treatment any longer? If you want to lighten those dark spots on your face, chest and hands with Clear™ or if you’re interested in other Obagi® products, give us a call at (909) 987-0899 or request a private consultation here. You’ll look better and feel so much better about your one and only face.

If you happen to know someone who has pigmentation problems, have them get in touch with us. If this type of problem goes untreated and if sun exposure continues, these areas can darken to the point where even make up won’t cover them.  Anyone that has struggled with these problems should know this firsthand.

deflated saline

deflated saline

The first thing you should do is call Dr. Haiavy at Inland Cosmetic Surgery!

It is possible that your breast implants are covered under a manufacturer’s warranty, which can often help to cover the replacement cost.  While a ruptured saline implant poses no immediate danger to the patient, it will certainly look and feel strange. Failure of a silicone breast implant on the other hand, can only be diagnosed by MRI.

Implant deflation is far from being a common occurrence but it can happen for a variety of reasons. In some cases, the problems occur because implants are filled beyond (or below) the manufacturer’s recommended fill range. Other times, texturing of a saline implant results in excessive wrinkling and premature wear, causing the implant to fail.

In the event of implant failure, safe removal and replacement can be achieved in a surgical procedure similar to the original breast augmentation. Usually the same incision is used to approach the deflated implant.

This all might sound like a major hassle, but there is good news; recovery from breast implant repair surgery is usually easier than the original surgery, since the pectoralis muscle has already been stretched.

If you haven’t already heard, a new eyelash-enhancing drug called Latisse has received FDA approval and is now available by prescription. Latisse is manufactured by Allergan Inc, maker of Botox and Juvederm.

When applied to the base of the lashes, Latisse keeps hairs in their growth phase, producing longer,thicker and darker lashes. The effects are not permanent;the patient must keep using Latisse to maintain the look and eyelashes return to normal after discontinued use.

Like many new drugs in recent years, positive side effects of the Latisse’ active ingredient came about inadvertently during late clinical trials of a drug called Lumigan, which was meant to treat glaucoma. Researchers documented an interesting, unintended effect of Lumigan; significantly longer, fuller eyelashes were seen in patients.

Further research and clinical trials were conducted and now Latisse is available to treat Hypotrichosis, or “inadequate eyelashes.”

Click here to see video of CBS 2 Los Angeles’ recent report on Latisse.

Contact us for more details on Latisse!

A diverse medical team of doctors and surgeons at Cleveland Clinic have performed the nation’s first ever 80 percent face transplant.

While personal details on the patient have been withheld, the clinic issued a press release stating that the patient is a female who had previously suffered serious facial trauma. During the procedure, many complex facial components of the patient’s face were restored.  Trained in microsurgery and transplantation techniques, the surgeons integrated facial structures like the nose and lower eyelids, while also replacing complex tissues like nerves, arteries and skin.

Dr. Maria Siemionow, director of Plastic surgery research and team leader for the project has spent her career researching and developing such procedures. She was able to direct professionals from a variety of disciplines. Surgery, transplant, anesthesia, opthamology, dentistry and bioethics are just a few of medical disciplines that played a significant role.

A multifaceted approach of this caliber is probably the only way to achieve such a complex surgical procedure.

Regarding the importance of facial surgery, Siemionow says, “No other aspect of our anatomy is capable of even a fraction of the complexity of motion and emotion allowed by the muscles and tissues of the face.”   She describes her motivation in a recent Wall Street Journal article saying,”Patients with facial disfigurement have very difficult challenges in society. We hope that one day we may be able to help the tens of thousands of patients who are quietly suffering.”

The United States’ foremost breast implant maker Mentor Corp. (MNT) succumbed to Johnson and Johnson (JNJ) at the stunning price of $1.1 billion on December 1, 2008.

With the declining market, Mentor tried to boost sales of silicone breast implants, which have typically generated twice the revenue as saline implants once the FDA had lifted the fourteen-year ban on them two years ago.

Michael Weinstein, a JP Morgan analyst, believes that the recent economic plunge has forced Mentor Corp. to give way to J&J, even though they will continue to stand alone.

Although 90% of Mentor’s income is generated from breast implants, they have decided to increase their profile by adding another product to their line – PurTox.

PurTox is a neurotoxin that fights facial wrinkles and the FDA is estimated to give it approval by mid to late 2010. When this happens, Allergan, the makers of Botox, will be in competition with whatever cutting edge or price break that PurTox has to offer.